What patients and families need to know
Pediatric Neurology Update
The Children’s National Hospital Center for Neuroscience and Behavioral Medicine, consistently ranked in the top 10 by U.S. News & World Report (5th in Neurology and Neurosurgery for 2019-2020), will host the 30th Annual Pediatric Neurology Update course on April 2, 2020. The Center is committed to translating the newest discoveries in child neurology to more effective treatments.
The course will feature two critical areas in pediatric neuroscience:
- Neuromuscular diseases with a special emphasis on the scientific, medical, ethical and financial implications of the new molecular genetic therapies for pediatric neuromuscular disease (including Werdnig-Hoffmann and Duchenne's Muscular Dystrophy); and
- Advances in neurocritical care.
Internationally-renowned speakers will complement talks from Children’s National faculty. This year’s course will feature two co-Richmond Paine Lecturers, Drs. Kevin Flanigan and Richard Finkel, who have been integral in the development and clinical testing of the new neuromuscular neurogenetic therapies. To complement their talks, representatives from the National Institutes of Health (Dr. Nina Schor from NINDS), the Food and Drug Administration (Dr. Wilson Bryan) and industry will speak and be part of an interactive round table discussion.
Learn more about the event and register to attend.